Source: International Congress 2014 – Mesothelioma: a never-ending story



Rating:

Share or cite this content

Citations should be made in the following way:
P. Baas (Amsterdam, Netherlands). New molecular-directed therapies for mesothelioma: have there been any advances?. International Congress 2014 – Mesothelioma: a never-ending story

Member's Comments

Bernard Yung - 02.11.2014 16:21
Thank you.

Sebastian Sohrab - 23.09.2014 18:11
Very good overview!

Related content which might interest you: Malignant mesothelioma: new treatment advances, including targeted therapies Source: Virtual Congress 2021 – Diagnostic and therapeutic advances in mesothelioma care Year: 2021 Bronchiectasis: new therapies and perspectives Source: International Congress 2018 – Bronchiectasis: new insights in diagnosis and treatment Year: 2018 Latest advances in systemic therapies Source: ERS Online Course 2019: Essentials of modern lung cancer care – catch up with the latest advances Year: 2019 New developments in radiotherapy Source: European Multidisciplinary Conference in Thoracic Oncology 2009 Year: 2009 New and anticipated therapeutic developments in management of non-small-cell lung cancer Source: Annual Congress 2013 –ERS/The Lancet/The Lancet Respiratory Medicine joint Lunchtime session on lung cancer Year: 2013 PG11 Modern approaches in lung cancer diagnostics and therapy Source: Paris 2018 - Educational material Year: 2018 Novel targets and emerging therapies in MPM Source: ERS Skills course: Multi-disciplinary care in thoracic oncology Year: 2019 Malignant pleural mesothelioma: new treatments, new hopes? Source: Eur Respir J , 49 (3) 1700319; DOI: 10.1183/13993003.00319-2017 Year: 2017 Update on biology and management of mesothelioma Source: Eur Respir Rev, 30 (159) 200226; 10.1183/16000617.0226-2020 Year: 2021 Combination immunotherapy in mesothelioma: managing expectations and new toxicities Source: Virtual Congress 2021 – Lung cancer grand round Year: 2021 Genomically-guided therapies: a new era for cystic fibrosis Source: Virtual Congress 2020 – European Reference Network for rare lung diseases (ERN-LUNG): acting for improved cross-border management of rare diseases Year: 2020 New and emerging targeted treatments in advanced lung cancer Source: International Congress 2016 – Lung cancer: latest developments in screening and patient management Year: 2016 Clinical implications and opportunities for new drug therapies Source: Annual Congress 2008 - Deadly networks: disease-causing protein and DNA modifications Year: 2008 New findings in the molecular biology of lung cancer: clinical application Source: European Multidisciplinary Conference in Thoracic Oncology 2009 Year: 2009